5β-Cholane activators of the farnesol X receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 94, Issue 4, 2005, Pages 311-318

  Fukuchi, Junichi ^a   Song, Ching ^a   Dai, Qing ^a   Hiipakka, Richard A ^a   Liao, Shutsung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 Cholane; Bile acids; FXR

Indexed keywords

5BETA 24 NORCHOLANE 23 SULFONIC ACID; 5BETA CHOLAN 24 OL; 5BETA CHOLANIC ACID METHYL ESTER; ANTILIPEMIC AGENT; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLANIC ACID DERIVATIVE; FARNESOID X RECEPTOR ACTIVATOR; GLYCOCHOLANIC ACID; HORMONE RECEPTOR STIMULATING AGENT; N CHLOROMETHYL 5BETA CHOLAN 24 AMIDE; N METHYL 5BETA GLYCOCHOLANIC ACID; N METHYL N METHOXY 5BETA CHOLAN 24 AMIDE; N METHYL N [(5BETA) 24 OXOCHOLAN 24 YL] N' FORMYLHYDRAZINE; N METHYL N [(5BETA) 24 OXOCHOLAN 24 YL] N' METHYLHYDRAZINE; N METHYL N [(5BETA) 24 OXOCHOLAN 24 YL]GLYCINE ETHYL ESTER; N TRIFLUOROMETHYL 5BETA CHOLAN 24 AMIDE; N,N DIMETHYL 5BETA CHOLAN 24 AMIDE; TAUROCHOLANIC ACID; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN; CELL RECEPTOR; CHOLANIC ACID; CHOLESTEROL; CHOLIC ACID DERIVATIVE; DNA BINDING PROTEIN; FARNESOID X RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; LIVER X RECEPTOR; MESSENGER RNA; N-METHYL-5BETA GLYCOCHOLANIC ACID; SREBF1 PROTEIN, MOUSE; SREBF1 PROTEIN, RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; EMBRYO; GENE EXPRESSION; GENE INDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOLIPEMIA; LIVER; MALE; NONHUMAN; RAT; REPORTER GENE; ANIMAL; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; DRUG POTENTIATION; FISCHER 344 RAT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CHOLESTEROL; CHOLIC ACIDS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; LIVER; MALE; MICE; RATS; RATS, INBRED F344; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 18044364831     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.11.012     Document Type: Article

References (26)

1. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
2. D.J. Parks, S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore, and J.M. Lehmann Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
3. H. Wang, J. Chen, K. Hollister, L.C. Sowers, and B.M. Forman Endogenous bile acids are ligands for the nuclear receptor FXR/BAR Mol. Cells 3 1999 543 553
4. B.A. Laffitte, H.R. Kast, C.M. Nguyen, A.M. Zavacki, D.D. Moore, and P.A. Edwards Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor J. Biol. Chem. 275 2000 10638 10647
5. B.M. Forman, E. Goode, J. Chen, A.E. Oro, D.J. Bradley, T. Perlmann, D.J. Noonan, L.T. Burka, T. McMorris, and W.W. Lamph Identification of a nuclear receptor that is activated by farnesol metabolites Cell 81 1995 687 693
6. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
7. T.T. Lu, M. Makishima, J.J. Repa, K. Schoonjans, T.A. Kerr, J. Auwerx, and D.J. Mangelsdorf Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors Mol. Cells 6 2000 507 515
8. B. Goodwin, S.A. Jones, R.R. Price, M.A. Watson, D.D. McKee, L.B. Moore, C. Galardi, J.G. Wilson, M.C. Lewis, M.E. Roth, P.R. Maloney, T.M. Willson, and S.A. Kliewer A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis Mol. Cells 6 2000 517 526
9. H.R. Kast, C.M. Nguyen, C.J. Sinal, S.A. Jones, B.A. Laffitte, K. Reue, F.J. Gonzalez, T.M. Willson, and P.A. Edwards Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids Mol. Endocrinol. 15 2001 1720 1728
10. P.A. Mak, H.R. Kast-Woelbern, A.M. Anisfeld, and P.A. Edwards Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors J. Lipid Res. 43 2002 2037 2041
11. P.R. Maloney, D.J. Parks, C.D. Haffner, A.M. Fivush, G. Chandra, K.D. Plunket, K.L. Creech, L.B. Moore, J.G. Wilson, M.C. Lewis, S.A. Jones, and T.M. Willson Identification of a chemical tool for the orphan nuclear receptor FXR J. Med. Chem. 43 2000 2971 2974
12. I. Dussault, R. Beard, M. Lin, K. Hollister, J. Chen, J.H. Xiao, R. Chandraratna, and B.M. Forman Identification of gene-selective modulators of the bile acid receptor FXR J. Biol. Chem. 278 2003 7027 7033
13. N.L. Urizar, A.B. Liverman, D.T. Dodds, F.V. Silva, P. Ordentlich, Y. Yan, F.J. Gonzalez, R.A. Heyman, D.J. Mangelsdorf, and D.D. Moore A natural product that lowers cholesterol as an antagonist ligand for FXR Science 296 2002 1703 1706
14. C. Song, R.A. Hiipakka, and S. Liao Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs Steroids 65 2000 423 427
15. H. Hong, K. Kohli, A. Trivedi, D.L. Johnson, and M.R. Stallcup GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors Proc. Natl. Acad. Sci. U.S.A. 93 1996 4948 4952
16. J. Kokontis, K. Takakura, N. Hay, and S. Liao Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation Cancer Res. 54 1994 1566 1573
17. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual second ed. 1989 Cold Spring Harbor Laboratory Press New York
18. L.Z. Mi, S. Devarakonda, J.M. Harp, Q. Han, R. Pellicciari, T.M. Willson, S. Khorasanizadeh, and F. Rastinejad Structural basis for bile acid binding and activation of the nuclear receptor FXR Mol. Cells 11 2003 1093 1100
19. N.L. Urizar, D.H. Dowhan, and D.D. Moore The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression J. Biol. Chem. 275 2000 39313 39317
20. H. Shimano, N. Yahagi, M. Amemiya-Kudo, A.H. Hasty, J. Osuga, Y. Tamura, F. Shionoiri, Y. Iizuka, K. Ohashi, K. Harada, T. Gotoda, S. Ishibashi, and N. Yamada Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes J. Biol. Chem. 274 1999 35832 35839
21. J.R. Schultz, H. Tu, A. Luk, J.J. Repa, J.C. Medina, L. Li, S. Schwendner, S. Wang, M. Thoolen, D.J. Mangelsdorf, K.D. Lustig, and B. Shan Role of LXRs in control of lipogenesis Genes Dev. 14 2000 2831 2838
22. C. Brendel, K. Schoonjans, O.A. Botrugno, E. Treuter, and J. Auwerx The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity Mol. Endocrinol. 16 2002 2065 2076
23. S.B. Joseph, and P. Tontonoz LXRs: new therapeutic targets in atherosclerosis? Curr. Opin. Pharmacol. 3 2003 192 197
24. S.B. Joseph, E. McKilligin, L. Pei, M.A. Watson, A.R. Collins, B.A. Laffitte, M. Chen, G. Noh, J. Goodman, G.N. Hagger, J. Tran, T.K. Tippin, X. Wang, A.J. Lusis, W.A. Hsueh, R.E. Law, J.L. Collins, T.M. Willson, and P. Tontonoz Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proc. Natl. Acad. Sci. U.S.A. 99 2002 7604 7609
25. N. Terasaka, A. Hiroshima, T. Koieyama, N. Ubukata, Y. Morikawa, D. Nakai, and T. Inaba T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice FEBS Lett. 536 2003 6 11
26. J.W. Chisholm, J. Hong, S.A. Mills, and R.M. Lawn The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse J. Lipid Res. 44 2003 2039 2048